Romero-Macías, J.R.; Pascual-Serra, R.; Roche, O.; Ruiz-Marcos, F.; Serrano-Martínez, A.; González-Aguado, P.; Belandia, B.; Ruiz-Hidalgo, M.J.; Sánchez-Prieto, R. "Blockage of autophagic flux is associated with lymphocytosis and higher percentage of tumoral cells in chronic lymphocytic leukemia of B cells.". Clin Transl Oncol. 21(9): 1280-1285. (2019). (PMID: 30680609).
Fernández-Aroca, D.M.; Roche, O.; Sabater, S.; Pascual-Serra, R.; Ortega-Muelas, M.; Sánchez Pérez, I.; Belandia, B.; Ruiz-Hidalgo, M.J.; Sánchez-Prieto, R. "P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy.". Cancer Lett.. 451(): 23-33. (2019). (PMID: 30872077).
Serrano-Oviedo, L.; Ortega-Muelas, M.; García-Cano, J.; Valero, M.L.; Cimas, F.J.; Pascual-Serra, R.; Fernandez-Aroca, D.M.; Roche, O.; Ruiz-Hidalgo, M.J.; Belandia, B.; Giménez-Bachs, J.M.; Salinas, A.S.; Sanchez-Prieto, R. "Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion.". PLoS ONE. 13(7): e0200878. (2018). (PMID: 30048489).
López-Mateo, I.; Arruabarrena-Aristorena, A.; Artaza-Irigaray, C.; López, J.A.; Calvo, E.; Belandia, B. "HEY1 functions are regulated by its phosphorylation at Ser-68.". Biosci. Rep.. 36(3): . (2016). (PMID: 27129302).
López-Mateo, I.; Villaronga, M.Á.; Llanos, S.; Belandia, B. "The transcription factor CREBZF is a novel positive regulator of p53.". Cell Cycle. 11(20): 3887-3895. (2012). (PMID: 22983008).
Villaronga, M.A.; López-Mateo, I.; Markert, L.; Espinosa, E.; Fresno Vara, J.A.; Belandia, B. "Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient.". Breast Cancer Res. Treat.. 128(3): 891-898. (2011). (PMID: 21465167).
Lavery, D.N.; Villaronga, M.A.; Walker, M.M.; Patel, A.; Belandia, B.; Bevan, C.L. "Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors.". J. Biol. Chem.. 286(20): 17796-17808. (2011). (PMID: 21454491).
Villaronga, M.A.; Bevan, C.L.; Belandia, B. "Notch signaling: a potential therapeutic target in prostate cancer.". Curr Cancer Drug Targets. 8(7): 566-580. (2008). (PMID: 18991567).
García-Pedrero, J.M.; Kiskinis, E.; Parker, M.G.; Belandia, B. "The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells.". J. Biol. Chem.. 281(32): 22656-22664. (2006). (PMID: 16769725).
Kiskinis, E.; García-Pedrero, J.M.; Villaronga, M.A.; Parker, M.G.; Belandia, B. "Identification of BAF57 mutations in human breast cancer cell lines.". Breast Cancer Res. Treat.. 98(2): 191-198. (2006). (PMID: 16538531).
Belandia, B.; Parker, M.G. "Nuclear receptor regulation gears up another Notch.". Nucl Recept Signal. 4(): e001. (2006). (PMID: 16604164).
Belandia, B.; Powell, S.M.; García-Pedrero, J.M.; Walker, M.M.; Bevan, C.L.; Parker, M.G. "Hey1, a mediator of notch signaling, is an androgen receptor corepressor.". Mol. Cell. Biol.. 25(4): 1425-1436. (2005). (PMID: 15684393).
Villa, A.; Santiago, J.; Belandia, B.; Pascual, A. "A response unit in the first exon of the beta-amyloid precursor protein gene containing thyroid hormone receptor and Sp1 binding sites mediates negative regulation by 3,5,3'-triiodothyronine.". Mol. Endocrinol.. 18(4): 863-873. (2004). (PMID: 14715929).
Belandia, B.; Parker, M.G. "Nuclear receptors: a rendezvous for chromatin remodeling factors.". Cell. 114(3): 277-280. (2003). (PMID: 12914692).
Belandia, B.; Parker, M.G. "Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors.". J. Biol. Chem.. 275(40): 30801-30805. (2000). (PMID: 10934189).
Belandia, B.; Latasa, M.J.; Villa, A.; Pascual, A. "Thyroid hormone negatively regulates the transcriptional activity of the beta-amyloid precursor protein gene.". J. Biol. Chem.. 273(46): 30366-30371. (1998). (PMID: 9804800).
Latasa, M.J.; Belandia, B.; Pascual, A. "Thyroid hormones regulate beta-amyloid gene splicing and protein secretion in neuroblastoma cells.". Endocrinology. 139(6): 2692-2698. (1998). (PMID: 9607774).
Lerga, A.; Belandia, B.; Delgado, M.D.; Cuadrado, M.A.; Richard, C.; Ortiz, J.M.; Martín-Perez, J.; León, J. "Down-regulation of c-Myc and Max genes is associated to inhibition of protein phosphatase 2A in K562 human leukemia cells.". Biochem. Biophys. Res. Commun.. 215(3): 889-895. (1995). (PMID: 7488057).
Belandia, B.; Brautigan, D.; Martín-Pérez, J. "Attenuation of ribosomal protein S6 phosphatase activity in chicken embryo fibroblasts transformed by Rous sarcoma virus.". Mol. Cell. Biol.. 14(1): 200-206. (1994). (PMID: 8264587).
Instituto de Investigaciones Biomédicas "Alberto Sols"
C/Arturo Duperier 4. 28029 Madrid. (Spain)
Tel +(34) 91 585 4400 // Fax +(34) 91 558 4401 Email:Info